The expression of VEGFR2 and PDGFRwere not significantly different following treatment
The expression of VEGFR2 and PDGFRwere not significantly different following treatment. pancreatic malignancy that may be dependent on aberrant activation by stromal-derived FGF ligands. Keywords:pancreatic malignancy, fibroblast growth element receptor, predictive biomarker, tyrosine kinase inhibitor Pancreatic malignancy remains a highly fatal disease despite efforts to improve the treatment over last several decades (American Malignancy Society, 2011). Fibroblast growth YM 750 element receptors (FGFRs) are transmembrane proteins that, on binding with FGF ligands, result in the phosphorylation of FGFR substrate 2 (FRS2), a key adaptor protein that is largely specific to FGFRs (Wescheet al, 2011). Phosphorylated FRS2 then recruits and activates elements of the Ras/MAPK and PI3K/Akt pathways. Fibroblast growth element receptor signalling is YM 750 definitely terminated when the FGFFGFR complex is definitely endocytosed and ubiquitinatised. Fibroblast growth element receptor…